CD19 CAR - T 治疗后 B - ALL 复发患者的治疗和预后。
Mesh : Humans Antigens, CD19 / immunology Treatment Outcome Immunotherapy, Adoptive / methods Recurrence Male Female Receptors, Chimeric Antigen Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / therapy immunology Adult
来 源:
DOI:10.1186/s12967-024-05362-w
PDF(Pubmed)